Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

dbSNP Short Genetic Variations

Welcome to the Reference SNP (rs) Report

All alleles are reported in the Forward orientation. Click on the Variant Details tab for details on Genomic Placement, Gene, and Amino Acid changes. HGVS names are in the HGVS tab.

Reference SNP (rs) Report

This page reports data for a single dbSNP Reference SNP variation (RefSNP or rs) from the new redesigned dbSNP build.
Top of the page reports a concise summary for the rs, with more specific details included in the corresponding tabs below.
All alleles are reported in the Forward orientation. Use the Genomic View to inspect the nucleotides flanking the variant, and its neighbors.
For more information see Help documentation.

rs11045819

Current Build 156

Released September 21, 2022

Organism
Homo sapiens
Position
chr12:21176879 (GRCh38.p14) Help

The anchor position for this RefSNP. Includes all nucleotides potentially affected by this change, thus it can differ from HGVS, which is right-shifted. See here for details.

Alleles
C>A / C>T
Variation Type
SNV Single Nucleotide Variation
Frequency
A=0.121486 (32156/264690, TOPMED)
A=0.146491 (33538/228942, ALFA)
A=0.123871 (17333/139928, GnomAD) (+ 22 more)
A=0.116632 (14091/120816, ExAC)
A=0.07975 (6276/78698, PAGE_STUDY)
A=0.13544 (1758/12980, GO-ESP)
A=0.0687 (440/6404, 1000G_30x)
A=0.0649 (325/5008, 1000G)
A=0.0949 (425/4480, Estonian)
A=0.1580 (609/3854, ALSPAC)
A=0.1691 (627/3708, TWINSUK)
A=0.0599 (195/3256, PRJNA289433)
A=0.0003 (1/2922, KOREAN)
A=0.0747 (116/1552, HapMap)
A=0.0970 (110/1134, Daghestan)
A=0.184 (184/998, GoNL)
A=0.081 (51/626, Chileans)
A=0.143 (86/600, NorthernSweden)
A=0.142 (76/534, MGP)
A=0.066 (20/304, FINRISK)
A=0.060 (13/216, Qatari)
A=0.15 (13/88, PharmGKB)
C=0.48 (24/50, SGDP_PRJ)
A=0.10 (4/40, GENOME_DK)
C=0.4 (3/8, Siberian)
Clinical Significance
Reported in ClinVar
Gene : Consequence
SLCO1B1 : Missense Variant
Publications
30 citations
Genomic View
See rs on genome

ALFA Allele Frequency
The ALFA project provide aggregate allele frequency from dbGaP. More information is available on the project page including descriptions, data access, and terms of use.

Release Version: 20231103111315
Population Group Sample Size Ref Allele Alt Allele Ref HMOZ Alt HMOZ HTRZ HWEP
Total Global 245160 C=0.854507 A=0.145493, T=0.000000 0.732575 0.02356 0.243865 24
European Sub 202812 C=0.841735 A=0.158265, T=0.000000 0.709465 0.025995 0.264541 3
African Sub 12660 C=0.93499 A=0.06501, T=0.00000 0.876145 0.006161 0.117694 4
African Others Sub 440 C=0.968 A=0.032, T=0.000 0.940909 0.004545 0.054545 2
African American Sub 12220 C=0.93380 A=0.06620, T=0.00000 0.873813 0.006219 0.119967 3
Asian Sub 6442 C=0.9991 A=0.0009, T=0.0000 0.998137 0.0 0.001863 0
East Asian Sub 4562 C=0.9991 A=0.0009, T=0.0000 0.998246 0.0 0.001754 0
Other Asian Sub 1880 C=0.9989 A=0.0011, T=0.0000 0.997872 0.0 0.002128 0
Latin American 1 Sub 920 C=0.889 A=0.111, T=0.000 0.78913 0.01087 0.2 0
Latin American 2 Sub 3030 C=0.9343 A=0.0657, T=0.0000 0.873927 0.005281 0.120792 0
South Asian Sub 288 C=0.955 A=0.045, T=0.000 0.916667 0.006944 0.076389 1
Other Sub 19008 C=0.87226 A=0.12774, T=0.00000 0.765467 0.020939 0.213594 9


Help

Frequency tab displays a table of the reference and alternate allele frequencies reported by various studies and populations. Table lines, where Population="Global" refer to the entire study population, whereas lines, where Group="Sub", refer to a study-specific population subgroupings (i.e. AFR, CAU, etc.), if available. Frequency for the alternate allele (Alt Allele) is a ratio of samples observed-to-total, where the numerator (observed samples) is the number of chromosomes in the study with the minor allele present (found in "Sample size", where Group="Sub"), and the denominator (total samples) is the total number of all chromosomes in the study for the variant (found in "Sample size", where Group="Study-wide" and Population="Global").

Download
Study Population Group Sample Size Ref Allele Alt Allele
TopMed Global Study-wide 264690 C=0.878514 A=0.121486
Allele Frequency Aggregator Total Global 228942 C=0.853509 A=0.146491, T=0.000000
Allele Frequency Aggregator European Sub 192822 C=0.841559 A=0.158441, T=0.000000
Allele Frequency Aggregator Other Sub 17576 C=0.87443 A=0.12557, T=0.00000
Allele Frequency Aggregator African Sub 7864 C=0.9415 A=0.0585, T=0.0000
Allele Frequency Aggregator Asian Sub 6442 C=0.9991 A=0.0009, T=0.0000
Allele Frequency Aggregator Latin American 2 Sub 3030 C=0.9343 A=0.0657, T=0.0000
Allele Frequency Aggregator Latin American 1 Sub 920 C=0.889 A=0.111, T=0.000
Allele Frequency Aggregator South Asian Sub 288 C=0.955 A=0.045, T=0.000
gnomAD - Genomes Global Study-wide 139928 C=0.876129 A=0.123871
gnomAD - Genomes European Sub 75766 C=0.84546 A=0.15454
gnomAD - Genomes African Sub 41940 C=0.92110 A=0.07890
gnomAD - Genomes American Sub 13622 C=0.89921 A=0.10079
gnomAD - Genomes Ashkenazi Jewish Sub 3322 C=0.7881 A=0.2119
gnomAD - Genomes East Asian Sub 3126 C=0.9987 A=0.0013
gnomAD - Genomes Other Sub 2152 C=0.8913 A=0.1087
ExAC Global Study-wide 120816 C=0.883368 A=0.116632
ExAC Europe Sub 73058 C=0.83937 A=0.16063
ExAC Asian Sub 25132 C=0.97095 A=0.02905
ExAC American Sub 11502 C=0.93784 A=0.06216
ExAC African Sub 10226 C=0.92020 A=0.07980
ExAC Other Sub 898 C=0.894 A=0.106
The PAGE Study Global Study-wide 78698 C=0.92025 A=0.07975
The PAGE Study AfricanAmerican Sub 32514 C=0.91610 A=0.08390
The PAGE Study Mexican Sub 10810 C=0.92303 A=0.07697
The PAGE Study Asian Sub 8316 C=0.9986 A=0.0014
The PAGE Study PuertoRican Sub 7918 C=0.8836 A=0.1164
The PAGE Study NativeHawaiian Sub 4534 C=0.9513 A=0.0487
The PAGE Study Cuban Sub 4230 C=0.8624 A=0.1376
The PAGE Study Dominican Sub 3828 C=0.8851 A=0.1149
The PAGE Study CentralAmerican Sub 2450 C=0.9261 A=0.0739
The PAGE Study SouthAmerican Sub 1982 C=0.9051 A=0.0949
The PAGE Study NativeAmerican Sub 1260 C=0.8944 A=0.1056
The PAGE Study SouthAsian Sub 856 C=0.957 A=0.043
GO Exome Sequencing Project Global Study-wide 12980 C=0.86456 A=0.13544
GO Exome Sequencing Project European American Sub 8574 C=0.8392 A=0.1608
GO Exome Sequencing Project African American Sub 4406 C=0.9140 A=0.0860
1000Genomes_30x Global Study-wide 6404 C=0.9313 A=0.0687
1000Genomes_30x African Sub 1786 C=0.9362 A=0.0638
1000Genomes_30x Europe Sub 1266 C=0.8499 A=0.1501
1000Genomes_30x South Asian Sub 1202 C=0.9700 A=0.0300
1000Genomes_30x East Asian Sub 1170 C=0.9974 A=0.0026
1000Genomes_30x American Sub 980 C=0.901 A=0.099
1000Genomes Global Study-wide 5008 C=0.9351 A=0.0649
1000Genomes African Sub 1322 C=0.9402 A=0.0598
1000Genomes East Asian Sub 1008 C=0.9970 A=0.0030
1000Genomes Europe Sub 1006 C=0.8559 A=0.1441
1000Genomes South Asian Sub 978 C=0.970 A=0.030
1000Genomes American Sub 694 C=0.901 A=0.099
Genetic variation in the Estonian population Estonian Study-wide 4480 C=0.9051 A=0.0949
The Avon Longitudinal Study of Parents and Children PARENT AND CHILD COHORT Study-wide 3854 C=0.8420 A=0.1580
UK 10K study - Twins TWIN COHORT Study-wide 3708 C=0.8309 A=0.1691
MxGDAR/Encodat-PGx Global Study-wide 3256 C=0.9401 A=0.0599
MxGDAR/Encodat-PGx MxGDAR Sub 3256 C=0.9401 A=0.0599
KOREAN population from KRGDB KOREAN Study-wide 2922 C=0.9997 A=0.0003
HapMap Global Study-wide 1552 C=0.9253 A=0.0747
HapMap African Sub 692 C=0.964 A=0.036
HapMap American Sub 596 C=0.886 A=0.114
HapMap Europe Sub 174 C=0.868 A=0.132
HapMap Asian Sub 90 C=1.00 A=0.00
Genome-wide autozygosity in Daghestan Global Study-wide 1134 C=0.9030 A=0.0970
Genome-wide autozygosity in Daghestan Daghestan Sub 628 C=0.906 A=0.094
Genome-wide autozygosity in Daghestan Near_East Sub 144 C=0.903 A=0.097
Genome-wide autozygosity in Daghestan Central Asia Sub 122 C=0.934 A=0.066
Genome-wide autozygosity in Daghestan Europe Sub 106 C=0.811 A=0.189
Genome-wide autozygosity in Daghestan South Asian Sub 98 C=0.97 A=0.03
Genome-wide autozygosity in Daghestan Caucasus Sub 36 C=0.83 A=0.17
Genome of the Netherlands Release 5 Genome of the Netherlands Study-wide 998 C=0.816 A=0.184
Chileans Chilean Study-wide 626 C=0.919 A=0.081
Northern Sweden ACPOP Study-wide 600 C=0.857 A=0.143
Medical Genome Project healthy controls from Spanish population Spanish controls Study-wide 534 C=0.858 A=0.142
FINRISK Finnish from FINRISK project Study-wide 304 C=0.934 A=0.066
Qatari Global Study-wide 216 C=0.940 A=0.060
PharmGKB Aggregated Global Study-wide 88 C=0.85 A=0.15
PharmGKB Aggregated PA142898898 Sub 88 C=0.85 A=0.15
SGDP_PRJ Global Study-wide 50 C=0.48 A=0.52
The Danish reference pan genome Danish Study-wide 40 C=0.90 A=0.10
Siberian Global Study-wide 8 C=0.4 A=0.6
Help

Variant Details tab shows known variant placements on genomic sequences: chromosomes (NC_), RefSeqGene, pseudogenes or genomic regions (NG_), and in a separate table: on transcripts (NM_) and protein sequences (NP_). The corresponding transcript and protein locations are listed in adjacent lines, along with molecular consequences from Sequence Ontology. When no protein placement is available, only the transcript is listed. Column "Codon[Amino acid]" shows the actual base change in the format of "Reference > Alternate" allele, including the nucleotide codon change in transcripts, and the amino acid change in proteins, respectively, allowing for known ribosomal slippage sites. To view nucleotides adjacent to the variant use the Genomic View at the bottom of the page - zoom into the sequence until the nucleotides around the variant become visible.

Genomic Placements
Sequence name Change
GRCh38.p14 chr 12 NC_000012.12:g.21176879C>A
GRCh38.p14 chr 12 NC_000012.12:g.21176879C>T
GRCh37.p13 chr 12 NC_000012.11:g.21329813C>A
GRCh37.p13 chr 12 NC_000012.11:g.21329813C>T
SLCO1B1 RefSeqGene (LRG_1022) NG_011745.1:g.50686C>A
SLCO1B1 RefSeqGene (LRG_1022) NG_011745.1:g.50686C>T
Gene: SLCO1B1, solute carrier organic anion transporter family member 1B1 (plus strand)
Molecule type Change Amino acid[Codon] SO Term
SLCO1B1 transcript NM_006446.5:c.463C>A P [CCT] > T [ACT] Coding Sequence Variant
solute carrier organic anion transporter family member 1B1 NP_006437.3:p.Pro155Thr P (Pro) > T (Thr) Missense Variant
SLCO1B1 transcript NM_006446.5:c.463C>T P [CCT] > S [TCT] Coding Sequence Variant
solute carrier organic anion transporter family member 1B1 NP_006437.3:p.Pro155Ser P (Pro) > S (Ser) Missense Variant
Help

Clinical Significance tab shows a list of clinical significance entries from ClinVar associated with the variation, per allele. Click on the RCV accession (i.e. RCV000001615.2) or Allele ID (i.e. 12274) to access full ClinVar report.

Allele: A (allele ID: 324092 )
ClinVar Accession Disease Names Clinical Significance
RCV000364840.13 Rotor syndrome Benign
RCV001706464.2 not specified Benign
Help

Aliases tab displays HGVS names representing the variant placements and allele changes on genomic, transcript and protein sequences, per allele. HGVS name is an expression for reporting sequence accession and version, sequence type, position, and allele change. The column "Note" can have two values: "diff" means that there is a difference between the reference allele (variation interval) at the placement reported in HGVS name and the reference alleles reported in other HGVS names, and "rev" means that the sequence of this variation interval at the placement reported in HGVS name is in reverse orientation to the sequence(s) of this variation in other HGVS names not labeled as "rev".

Placement C= A T
GRCh38.p14 chr 12 NC_000012.12:g.21176879= NC_000012.12:g.21176879C>A NC_000012.12:g.21176879C>T
GRCh37.p13 chr 12 NC_000012.11:g.21329813= NC_000012.11:g.21329813C>A NC_000012.11:g.21329813C>T
SLCO1B1 RefSeqGene (LRG_1022) NG_011745.1:g.50686= NG_011745.1:g.50686C>A NG_011745.1:g.50686C>T
SLCO1B1 transcript NM_006446.5:c.463= NM_006446.5:c.463C>A NM_006446.5:c.463C>T
SLCO1B1 transcript NM_006446.4:c.463= NM_006446.4:c.463C>A NM_006446.4:c.463C>T
solute carrier organic anion transporter family member 1B1 NP_006437.3:p.Pro155= NP_006437.3:p.Pro155Thr NP_006437.3:p.Pro155Ser
Help

Submissions tab displays variations originally submitted to dbSNP, now supporting this RefSNP cluster (rs). We display Submitter handle, Submission identifier, Date and Build number, when the submission appeared for the first time. Direct submissions to dbSNP have Submission ID in the form of an ss-prefixed number (ss#). Other supporting variations are listed in the table without ss#.

112 SubSNP, 27 Frequency, 2 ClinVar submissions
No Submitter Submission ID Date (Build)
1 SC_SNP ss15510704 Feb 27, 2004 (120)
2 SC_SNP ss18962424 Feb 27, 2004 (120)
3 PERLEGEN ss24436893 Sep 20, 2004 (123)
4 AFFY ss66243318 Dec 01, 2006 (127)
5 PERLEGEN ss69103280 May 18, 2007 (127)
6 PHARMGKB_PAAR-SJCRH ss69368415 May 18, 2007 (127)
7 AFFY ss76389101 Dec 06, 2007 (129)
8 KRIBB_YJKIM ss82836258 Dec 15, 2007 (130)
9 HUMANGENOME_JCVI ss97292836 Feb 04, 2009 (130)
10 CNG ss98335765 Feb 04, 2009 (130)
11 ILLUMINA-UK ss118629317 Feb 14, 2009 (130)
12 PMT ss120239923 Dec 01, 2009 (131)
13 ENSEMBL ss139820661 Dec 01, 2009 (131)
14 SEATTLESEQ ss159725854 Dec 01, 2009 (131)
15 COMPLETE_GENOMICS ss170546303 Jul 04, 2010 (132)
16 AFFY ss173449978 Jul 04, 2010 (132)
17 BUSHMAN ss203633005 Jul 04, 2010 (132)
18 1000GENOMES ss225644845 Jul 14, 2010 (132)
19 1000GENOMES ss235854349 Jul 15, 2010 (132)
20 GMI ss286521388 Apr 25, 2013 (138)
21 PJP ss291397129 May 09, 2011 (134)
22 NHLBI-ESP ss342351442 May 09, 2011 (134)
23 1000GENOMES ss491038267 May 04, 2012 (137)
24 EXOME_CHIP ss491465334 May 04, 2012 (137)
25 CLINSEQ_SNP ss491661693 May 04, 2012 (137)
26 ILLUMINA ss780908754 Sep 08, 2015 (146)
27 ILLUMINA ss783596226 Sep 08, 2015 (146)
28 JMKIDD_LAB ss974482889 Aug 21, 2014 (142)
29 EVA-GONL ss989317037 Aug 21, 2014 (142)
30 JMKIDD_LAB ss1067532206 Aug 21, 2014 (142)
31 JMKIDD_LAB ss1078305415 Aug 21, 2014 (142)
32 1000GENOMES ss1344205393 Aug 21, 2014 (142)
33 HAMMER_LAB ss1397628255 Sep 08, 2015 (146)
34 EVA_GENOME_DK ss1576155893 Apr 01, 2015 (144)
35 EVA_FINRISK ss1584080711 Apr 01, 2015 (144)
36 EVA_DECODE ss1598989755 Apr 01, 2015 (144)
37 EVA_UK10K_ALSPAC ss1628166959 Apr 01, 2015 (144)
38 EVA_UK10K_TWINSUK ss1671160992 Apr 01, 2015 (144)
39 EVA_EXAC ss1690819637 Apr 01, 2015 (144)
40 EVA_MGP ss1711323287 Apr 01, 2015 (144)
41 EVA_SVP ss1713312649 Apr 01, 2015 (144)
42 ILLUMINA ss1752059974 Sep 08, 2015 (146)
43 ILLUMINA ss1917871585 Feb 12, 2016 (147)
44 WEILL_CORNELL_DGM ss1932681508 Feb 12, 2016 (147)
45 ILLUMINA ss1946333528 Feb 12, 2016 (147)
46 ILLUMINA ss1959419466 Feb 12, 2016 (147)
47 GENOMED ss1967542575 Jul 19, 2016 (147)
48 JJLAB ss2027088109 Sep 14, 2016 (149)
49 ILLUMINA ss2095032090 Dec 20, 2016 (150)
50 USC_VALOUEV ss2155413861 Dec 20, 2016 (150)
51 HUMAN_LONGEVITY ss2188375163 Dec 20, 2016 (150)
52 ILLUMINA ss2632934599 Nov 08, 2017 (151)
53 ILLUMINA ss2710756085 Nov 08, 2017 (151)
54 GNOMAD ss2739675632 Nov 08, 2017 (151)
55 GNOMAD ss2748826220 Nov 08, 2017 (151)
56 GNOMAD ss2908174493 Nov 08, 2017 (151)
57 AFFY ss2984969933 Nov 08, 2017 (151)
58 AFFY ss2985612467 Nov 08, 2017 (151)
59 SWEGEN ss3009330229 Nov 08, 2017 (151)
60 ILLUMINA ss3021413009 Nov 08, 2017 (151)
61 BIOINF_KMB_FNS_UNIBA ss3027350322 Nov 08, 2017 (151)
62 CSIRBIOHTS ss3029638259 Nov 08, 2017 (151)
63 CSHL ss3349960641 Nov 08, 2017 (151)
64 ILLUMINA ss3626833358 Oct 12, 2018 (152)
65 ILLUMINA ss3634494918 Oct 12, 2018 (152)
66 ILLUMINA ss3640202251 Oct 12, 2018 (152)
67 ILLUMINA ss3644586488 Oct 12, 2018 (152)
68 OMUKHERJEE_ADBS ss3646439196 Oct 12, 2018 (152)
69 URBANLAB ss3649786497 Oct 12, 2018 (152)
70 ILLUMINA ss3651787129 Oct 12, 2018 (152)
71 ILLUMINA ss3651787130 Oct 12, 2018 (152)
72 ILLUMINA ss3653742479 Oct 12, 2018 (152)
73 EGCUT_WGS ss3676645999 Jul 13, 2019 (153)
74 EVA_DECODE ss3693259735 Jul 13, 2019 (153)
75 ILLUMINA ss3725309278 Jul 13, 2019 (153)
76 ACPOP ss3738837089 Jul 13, 2019 (153)
77 ILLUMINA ss3744392907 Jul 13, 2019 (153)
78 ILLUMINA ss3744795631 Jul 13, 2019 (153)
79 EVA ss3750230589 Jul 13, 2019 (153)
80 PAGE_CC ss3771679146 Jul 13, 2019 (153)
81 ILLUMINA ss3772295155 Jul 13, 2019 (153)
82 KHV_HUMAN_GENOMES ss3815548196 Jul 13, 2019 (153)
83 EVA ss3824711160 Apr 26, 2020 (154)
84 EVA ss3825817688 Apr 26, 2020 (154)
85 EVA ss3833014591 Apr 26, 2020 (154)
86 SGDP_PRJ ss3877844635 Apr 26, 2020 (154)
87 KRGDB ss3926377258 Apr 26, 2020 (154)
88 FSA-LAB ss3984023421 Apr 26, 2021 (155)
89 EVA ss3984449716 Apr 26, 2021 (155)
90 EVA ss3986562204 Apr 26, 2021 (155)
91 TOPMED ss4911206335 Apr 26, 2021 (155)
92 EVA ss5237219029 Apr 26, 2021 (155)
93 EVA ss5237508213 Apr 26, 2021 (155)
94 EVA ss5237659607 Oct 13, 2022 (156)
95 1000G_HIGH_COVERAGE ss5290064486 Oct 13, 2022 (156)
96 TRAN_CS_UWATERLOO ss5314434915 Oct 13, 2022 (156)
97 HUGCELL_USP ss5484924546 Oct 13, 2022 (156)
98 EVA ss5510619766 Oct 13, 2022 (156)
99 EVA ss5512473922 Oct 13, 2022 (156)
100 1000G_HIGH_COVERAGE ss5587120832 Oct 13, 2022 (156)
101 SANFORD_IMAGENETICS ss5624296722 Oct 13, 2022 (156)
102 SANFORD_IMAGENETICS ss5652739654 Oct 13, 2022 (156)
103 EVA ss5800064724 Oct 13, 2022 (156)
104 EVA ss5800175371 Oct 13, 2022 (156)
105 EVA ss5837690626 Oct 13, 2022 (156)
106 EVA ss5847405672 Oct 13, 2022 (156)
107 EVA ss5847662852 Oct 13, 2022 (156)
108 EVA ss5848347705 Oct 13, 2022 (156)
109 EVA ss5903573690 Oct 13, 2022 (156)
110 EVA ss5944090223 Oct 13, 2022 (156)
111 EVA ss5979385026 Oct 13, 2022 (156)
112 EVA ss5980726511 Oct 13, 2022 (156)
113 1000Genomes NC_000012.11 - 21329813 Oct 12, 2018 (152)
114 1000Genomes_30x NC_000012.12 - 21176879 Oct 13, 2022 (156)
115 The Avon Longitudinal Study of Parents and Children NC_000012.11 - 21329813 Oct 12, 2018 (152)
116 Chileans NC_000012.11 - 21329813 Apr 26, 2020 (154)
117 Genome-wide autozygosity in Daghestan NC_000012.10 - 21221080 Apr 26, 2020 (154)
118 Genetic variation in the Estonian population NC_000012.11 - 21329813 Oct 12, 2018 (152)
119 ExAC NC_000012.11 - 21329813 Oct 12, 2018 (152)
120 FINRISK NC_000012.11 - 21329813 Apr 26, 2020 (154)
121 The Danish reference pan genome NC_000012.11 - 21329813 Apr 26, 2020 (154)
122 gnomAD - Genomes NC_000012.12 - 21176879 Apr 26, 2021 (155)
123 gnomAD - Exomes

Submission ignored due to conflicting rows:
Row 8903565 (NC_000012.11:21329812:C:C 221540/250104, NC_000012.11:21329812:C:A 28564/250104)
Row 8903566 (NC_000012.11:21329812:C:C 250103/250104, NC_000012.11:21329812:C:T 1/250104)

- Jul 13, 2019 (153)
124 gnomAD - Exomes

Submission ignored due to conflicting rows:
Row 8903565 (NC_000012.11:21329812:C:C 221540/250104, NC_000012.11:21329812:C:A 28564/250104)
Row 8903566 (NC_000012.11:21329812:C:C 250103/250104, NC_000012.11:21329812:C:T 1/250104)

- Jul 13, 2019 (153)
125 GO Exome Sequencing Project NC_000012.11 - 21329813 Oct 12, 2018 (152)
126 Genome of the Netherlands Release 5 NC_000012.11 - 21329813 Apr 26, 2020 (154)
127 HapMap NC_000012.12 - 21176879 Apr 26, 2020 (154)
128 KOREAN population from KRGDB NC_000012.11 - 21329813 Apr 26, 2020 (154)
129 Medical Genome Project healthy controls from Spanish population NC_000012.11 - 21329813 Apr 26, 2020 (154)
130 Northern Sweden NC_000012.11 - 21329813 Jul 13, 2019 (153)
131 The PAGE Study NC_000012.12 - 21176879 Jul 13, 2019 (153)
132 MxGDAR/Encodat-PGx NC_000012.11 - 21329813 Apr 26, 2021 (155)
133 PharmGKB Aggregated NC_000012.12 - 21176879 Apr 26, 2020 (154)
134 Qatari NC_000012.11 - 21329813 Apr 26, 2020 (154)
135 SGDP_PRJ NC_000012.11 - 21329813 Apr 26, 2020 (154)
136 Siberian NC_000012.11 - 21329813 Apr 26, 2020 (154)
137 TopMed NC_000012.12 - 21176879 Apr 26, 2021 (155)
138 UK 10K study - Twins NC_000012.11 - 21329813 Oct 12, 2018 (152)
139 ALFA NC_000012.12 - 21176879 Apr 26, 2021 (155)
140 ClinVar RCV000364840.13 Oct 13, 2022 (156)
141 ClinVar RCV001706464.2 Oct 13, 2022 (156)
Help

History tab displays RefSNPs (Associated ID) from previous builds (Build) that now support the current RefSNP, and the dates, when the history was updated for each Associated ID (History Updated).

Associated ID History Updated (Build)
rs17389312 Oct 08, 2004 (123)
rs60034088 Feb 26, 2009 (130)
Added to this RefSNP Cluster:
Submission IDs Observation SPDI Canonical SPDI Source RSIDs
99230, ss66243318, ss76389101, ss118629317, ss170546303, ss173449978, ss203633005, ss286521388, ss291397129, ss491661693, ss1397628255, ss1598989755, ss1713312649 NC_000012.10:21221079:C:A NC_000012.12:21176878:C:A (self)
56923990, 31607567, 94340, 22384247, 1109578, 77172, 2875600, 1168645, 14103382, 33554652, 439047, 12121954, 2717, 14723438, 29861615, 7930215, 31607567, ss225644845, ss235854349, ss342351442, ss491038267, ss491465334, ss780908754, ss783596226, ss974482889, ss989317037, ss1067532206, ss1078305415, ss1344205393, ss1576155893, ss1584080711, ss1628166959, ss1671160992, ss1690819637, ss1711323287, ss1752059974, ss1917871585, ss1932681508, ss1946333528, ss1959419466, ss1967542575, ss2027088109, ss2095032090, ss2155413861, ss2632934599, ss2710756085, ss2739675632, ss2748826220, ss2908174493, ss2984969933, ss2985612467, ss3009330229, ss3021413009, ss3029638259, ss3349960641, ss3626833358, ss3634494918, ss3640202251, ss3644586488, ss3646439196, ss3651787129, ss3651787130, ss3653742479, ss3676645999, ss3738837089, ss3744392907, ss3744795631, ss3750230589, ss3772295155, ss3824711160, ss3825817688, ss3833014591, ss3877844635, ss3926377258, ss3984023421, ss3984449716, ss3986562204, ss5237508213, ss5510619766, ss5512473922, ss5624296722, ss5652739654, ss5800064724, ss5800175371, ss5837690626, ss5847405672, ss5847662852, ss5848347705, ss5944090223, ss5979385026, ss5980726511 NC_000012.11:21329812:C:A NC_000012.12:21176878:C:A (self)
RCV000364840.13, RCV001706464.2, 74646767, 401379545, 771113, 900615, 2675, 126751992, 3424572721, ss2188375163, ss3027350322, ss3649786497, ss3693259735, ss3725309278, ss3771679146, ss3815548196, ss4911206335, ss5237219029, ss5237659607, ss5290064486, ss5314434915, ss5484924546, ss5587120832, ss5903573690 NC_000012.12:21176878:C:A NC_000012.12:21176878:C:A (self)
ss15510704, ss18962424 NT_009714.16:14088786:C:A NC_000012.12:21176878:C:A (self)
ss24436893, ss69103280, ss69368415, ss82836258, ss97292836, ss98335765, ss120239923, ss139820661, ss159725854 NT_009714.17:14089936:C:A NC_000012.12:21176878:C:A (self)
ss2739675632 NC_000012.11:21329812:C:T NC_000012.12:21176878:C:T (self)
3424572721 NC_000012.12:21176878:C:T NC_000012.12:21176878:C:T (self)
Help

Publications tab displays PubMed articles citing the variation as a listing of PMID, Title, Author, Year, Journal, ordered by Year, descending.

30 citations for rs11045819
PMID Title Author Year Journal
18781850 Association between a frequent allele of the gene encoding OATP1B1 and enhanced LDL-lowering response to fluvastatin therapy. Couvert P et al. 2008 Pharmacogenomics
20078617 The impact of SLCO1B1 polymorphisms on the plasma concentration of lopinavir and ritonavir in HIV-infected men. Kohlrausch FB et al. 2010 British journal of clinical pharmacology
20139798 ADME pharmacogenetics: investigation of the pharmacokinetics of the antiretroviral agent lopinavir coformulated with ritonavir. Lubomirov R et al. 2010 Pharmacogenetics and genomics
20435227 Clinical assessment incorporating a personal genome. Ashley EA et al. 2010 Lancet (London, England)
20973885 Organic anion transporter 1B1 (SLCO1B1) polymorphism and gallstone formation: High incidence of Exon4 CA genotype in female patients in North India. Srivastava A et al. 2011 Hepatology research
21072184 Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition. Ni W et al. 2010 PloS one
21288825 Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study. Lubomirov R et al. 2011 The Journal of infectious diseases
21573225 Genetic background of patients from a university medical center in Manhattan: implications for personalized medicine. Tayo BO et al. 2011 PloS one
21709081 The SLCO1B1 rs4149032 polymorphism is highly prevalent in South Africans and is associated with reduced rifampin concentrations: dosing implications. Chigutsa E et al. 2011 Antimicrobial agents and chemotherapy
22016628 Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response. Rodrigues AC et al. 2011 International journal of molecular sciences
22136368 Influence of genomic ancestry on the distribution of SLCO1B1, SLCO1B3 and ABCB1 gene polymorphisms among Brazilians. Sortica Vde A et al. 2012 Basic & clinical pharmacology & toxicology
22275900 Pharmacogenomics: what is next? di Iulio J et al. 2011 Frontiers in pharmacology
22552919 Bioinformatics and variability in drug response: a protein structural perspective. Lahti JL et al. 2012 Journal of the Royal Society, Interface
23100282 Impact of common genetic variation on response to simvastatin therapy among 18 705 participants in the Heart Protection Study. Hopewell JC et al. 2013 European heart journal
23133420 Pharmacogenomic Diversity among Brazilians: Influence of Ancestry, Self-Reported Color, and Geographical Origin. Suarez-Kurtz G et al. 2012 Frontiers in pharmacology
23503447 Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146. Zhang X et al. 2013 Therapeutic drug monitoring
23940529 Roles of genetic polymorphisms in the folate pathway in childhood acute lymphoblastic leukemia evaluated by Bayesian relevance and effect size analysis. Lautner-Csorba O et al. 2013 PloS one
24122874 Interindividual variability in hepatic organic anion-transporting polypeptides and P-glycoprotein (ABCB1) protein expression: quantification by liquid chromatography tandem mass spectroscopy and influence of genotype, age, and sex. Prasad B et al. 2014 Drug metabolism and disposition
24909419 A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics? Baietto L et al. 2014 Current drug metabolism
26482301 Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis. Hennig S et al. 2016 Antimicrobial agents and chemotherapy
26744986 Mixed effects of OATP1B1, BCRP and NTCP polymorphisms on the population pharmacokinetics of pravastatin in healthy volunteers. Lu XF et al. 2016 Xenobiotica; the fate of foreign compounds in biological systems
27398328 Hyperbilirubinemia in Neonates: Types, Causes, Clinical Examinations, Preventive Measures and Treatments: A Narrative Review Article. Ullah S et al. 2016 Iranian journal of public health
27510251 SLCO1B1 gene polymorphisms do not influence plasma rifampicin concentrations in a South Indian population. Ramesh K et al. 2016 The international journal of tuberculosis and lung disease
31250727 The pharmacogenetics of OATP1B1 variants and their impact on the pharmacokinetics and efficacy of elbasvir/grazoprevir. Guo Z et al. 2019 Pharmacogenomics
31777781 Association of SLCO1B1 *14 Allele with Poor Response to Methotrexate in Juvenile Idiopathic Arthritis Patients. Ramsey LB et al. 2019 ACR open rheumatology
32022294 Influence of SLCO1B1 polymorphisms on lopinavir C(trough) in Serbian HIV/AIDS patients. Dragović G et al. 2020 British journal of clinical pharmacology
33875422 Pharmacogene Sequencing of a Gabonese Population with Severe Plasmodium falciparum Malaria Reveals Multiple Novel Variants with Putative Relevance for Antimalarial Treatment. Pernaute-Lau L et al. 2021 Antimicrobial agents and chemotherapy
34423897 SLCO1B1 *15 allele is associated with methotrexate-induced nausea in pediatric patients with inflammatory bowel disease. Mehta RS et al. 2022 Clinical and translational science
35693129 Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review. Sileshi T et al. 2022 Pharmacogenomics and personalized medicine
36055153 SLCO1B1 and SLC10A1 polymorphism and plasma rifampin concentrations in patients with co-morbidity tuberculosis-diabetes mellitus in Baja California, Mexico. Perea-Jacobo R et al. 2022 Tuberculosis (Edinburgh, Scotland)
Help

The Flanks tab provides retrieving flanking sequences of a SNP on all molecules that have placements.

Genome context:
Select flank length:

Genomic regions, transcripts, and products
Top Help

NCBI Graphical Sequence Viewer display of the genomic region, transcripts and protein products for the reported RefSNP (rs).
Use the zoom option to view the nucleotides around the RefSNP and find other neighboring RefSNPs.
Visit Sequence Viewer for help with navigating inside the display and modifying the selection of displayed data tracks.

Software version is: 2.0.1.post825+45319f0